Natural performance backed by science Ubiquinol and Glavonoid™ offer natural efficacy and safety
Brussels (Belgium), September 2014 – HiE, Amsterdam, 2nd – 4th December, booth K20 – Kaneka Pharma Europe highlights functional ingredients to support health for body and mind. The focus will be on the scientifically backed and naturally produced ingredients Ubiquinol and Glavonoid™. Ubiquinol, the active form of coenzyme Q10 with higher bioavailability, is essential for the body’s energy production and furthermore protects cells from oxidative damage. The licorice extract Glavonoid™ helps to reduce visceral fat. Both substances can be used in single ingredient supplement applications as well as in functional food combinations.
Ubiquinol is found in every human cell and is an essential part of the respiratory chain, which produces more than 95 percent of the energy the body needs to sustain its vital functions. It is also the only naturally occurring lipid soluble antioxidant that counteracts the aging process and protects cells from free radical damage. Ubiquinol is therefore crucial for a healthy body and high level performance – mentally as well as physically. Due to its high bioavailability and its ready-to-use form, Ubiquinol has a more rapid and better effect than coenzyme Q10, which has to be converted by the body before it can be used. Filip Van hulle, Sales and Marketing Manager at Kaneka Pharma Europe, comments: “Backed by numerous scientific studies, Ubiquinol offers a huge variety of health benefits. This allows manufacturers of nutritional supplements and functional foods to target a broad spectrum of consumers.” One example is Ubiquinol Omega-3 Aktiv-Formula capsules from the German company Biogenial. These have been inspired by findings that Inuit, whose natural diet is rich in Omega-3 fatty acids as well as coenzyme Q10, have a low prevalence of heart disease. By combining omega-3 fatty acids of marine origin and Ubiquinol, the capsules can contribute to the normal function of the heart. Kaneka QH™ Ubiquinol is suitable for use in soft gel capsules, pellets and sticks, as well as in foodstuffs.
Kaneka will also be presenting its Novel Food-approved licorice extract Glavonoid™. Because of its patented manufacturing process, the extract is free from glycyrrhizinic acid and therefore free from any associated cortisone-like side effects. Glavonoid™ offers a unique dual action in fighting visceral fat, thanks to its ability to activate the body’s fat metabolism and suppress fat synthesis. Studies have demonstrated that an intake of 100 mg Glavonoid™ per day burns 130 kcal of body fat. The extract can be processed in food supplements and beverages based on milk, yogurt, fruit and vegetables. Suitable for all kinds of weight management products, it can also be included in products aimed at the sports and fitness market, as well as healthy aging.
About Kaneka Pharma Europe
Kaneka Pharma Europe is based in Brussels. It is a full subsidiary of Kaneka Japan, the world’s leading supplier of coenzyme Q10 and the only supplier of Ubiquinol (the active form of coenzyme Q10).
Kaneka was founded in 1949 and is the only company to use natural yeast fermentation technology to produce coenzyme Q10. Kaneka Q10™ is the only self-affirmed GRAS coenzyme Q10 andcan be globally sourced from two production sites in theUS andJapan, as well as from Kaneka’s warehouses inBrussels.
Kaneka also developed the licorice root extract Glavonoid™, which supports the reduction of visceral fat. With Novel Food approval having been granted in November 2011, the first products are now available on the European market.
Kaneka’s company philosophy is based on a strong scientific grounding. Accordingly, the efficacy and safety of Kaneka Q10™, Ubiquinol and Glavonoid™ are well proven, and backed by a large number of scientific studies.
For further information, please visit:
www.ubiquinol.org www.KanekaQ10.info www.kanekaQH.info
